The medical community is updating the understanding of Polycystic Ovary Syndrome (PCOS), a common hormonal condition affecting women. Despite its name, many individuals with PCOS do not actually have ovarian cysts. The condition is now being more accurately termed polyendocrine metabolic ovarian syndrome (PMOS) to reflect its broader impact. Experts emphasize that PMOS is increasingly recognized as a systemic hormonal and metabolic disorder, not solely a reproductive issue. This renaming aims to improve diagnosis and treatment approaches, acknowledging the wider range of symptoms experienced by those affected. The shift in terminology is expected to better inform long-term health management for individuals with the condition. This redefinition highlights the need for a more holistic understanding of PMOS and its effects beyond the ovaries.